CA Stock MarketDetailed Quotes
AQS Aequus Pharmaceuticals Inc
- 0.005
- 0.0000.00%
15min DelayTrading Dec 11 16:00 ET
663.17KMarket Cap-0.50P/E (TTM)
0.000High0.000Low0Volume0.000Open0.005Pre Close0.00Turnover0.04052wk High0.00%Turnover Ratio132.63MShares0.00552wk Low-0.01EPS TTM563.98KFloat Cap0.800Historical HighLossP/E (Static)112.80MShs Float0.005Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-0.11P/B1Lot Size--Div YieldTTM
Aequus Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 46.33%-348.7K | -48.61%-706.1K | -95.40%-521.7K | -17.48%-2.29M | -102.06%-902.11K | -20.54%-649.73K | 44.18%-475.15K | -130.56%-266.99K | -66.57%-1.95M | 4.55%-446.47K |
| Net income from continuing operations | 23.51%-614.73K | 2.55%-683.03K | 11.05%-662.09K | 7.64%-2.96M | 29.86%-715.87K | -60.58%-803.65K | 9.23%-700.88K | 18.82%-744.32K | -77.39%-3.21M | -211.76%-1.02M |
| Operating gains losses | -93.26%275 | ---- | ---- | 100.21%88 | -439,600.00%-4.4K | 112.42%4.08K | ---- | ---- | -1,154.85%-41.16K | -99.98%1 |
| Depreciation and amortization | -4.79%33.08K | -4.79%33.08K | -4.79%33.08K | 6.42%138.16K | -2.57%33.92K | 9.71%34.75K | 9.71%34.75K | 9.71%34.75K | 1.34%129.83K | 70.65%34.82K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --566.76K | ---- |
| Remuneration paid in stock | -27.15%8.02K | -34.01%17.45K | 70.02%7.86K | 24.36%50.92K | 104.13%8.84K | 1,356.48%11.01K | 63.21%26.45K | -76.49%4.62K | -81.02%40.94K | -84.10%4.33K |
| Other non cashItems | -14.25%14.17K | -13.10%14.63K | -11.05%15.24K | -42.44%66.49K | -15.93%16K | 262.86%16.52K | -37.45%16.84K | -73.65%17.13K | -56.87%115.53K | -70.83%19.04K |
| Change In working capital | 140.37%210.49K | -159.96%-88.31K | -79.99%84.21K | -6.84%415.08K | -373.39%-240.61K | 305.13%87.57K | 206.44%147.29K | -37.88%420.83K | 1,441.02%445.57K | 80.28%-50.83K |
| -Change in receivables | 192.55%54.65K | -846.63%-83.76K | -101.44%-4.44K | -54.97%278.41K | 208.34%38.14K | -453.72%-59.05K | 74.58%-8.85K | -54.11%308.17K | 469.56%618.23K | 87.21%-35.2K |
| -Change in inventory | 141.06%62.5K | -329.19%-84.35K | 86.22%46.31K | -165.05%-29.92K | 67.04%60.61K | -693.47%-152.2K | 241.31%36.81K | 145.72%24.87K | 378.74%46K | 373.11%36.28K |
| -Change in prepaid assets | 38.65%-17.55K | 1,610.67%20.03K | -105.94%-9.22K | 208.18%138.98K | 108.15%11.07K | -7.11%-28.6K | -98.90%1.17K | 316.10%155.33K | -280.81%-128.47K | -8,482.75%-135.87K |
| -Change in payables and accrued expense | -66.13%110.89K | -49.42%59.77K | 176.34%51.56K | 130.62%27.61K | -517.38%-350.43K | 661.40%327.42K | 164.39%118.16K | -199.79%-67.54K | -163.67%-90.19K | 630.70%83.96K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 46.33%-348.7K | -48.61%-706.1K | -95.40%-521.7K | -17.48%-2.29M | -102.06%-902.11K | -20.54%-649.73K | 44.18%-475.15K | -130.56%-266.99K | -66.57%-1.95M | 4.55%-446.47K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -54.88%330.02K | 10.14%508.14K | 867.32%593.55K | 1,270.46%2.21M | 1,511.63%960.29K | 2,038.92%731.36K | 1,109.10%461.36K | 262.67%61.36K | -107.89%-189.19K | -83.32%-68.03K |
| Net issuance payments of debt | -54.88%330.02K | 10.14%508.14K | 867.32%593.55K | 1,270.46%2.21M | 1,511.63%960.29K | 2,038.92%731.36K | 1,109.10%461.36K | 262.67%61.36K | -28.26%-189.19K | -83.32%-68.03K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -54.88%330.02K | 10.14%508.14K | 867.32%593.55K | 1,270.46%2.21M | 1,511.63%960.29K | 2,038.92%731.36K | 1,109.10%461.36K | 262.67%61.36K | -107.89%-189.19K | -83.32%-68.03K |
| Net cash flow | ||||||||||
| Beginning cash position | 45.05%44.08K | 447.85%242.04K | -31.87%170.2K | -89.55%249.82K | -86.16%112.02K | -97.81%30.39K | -98.06%44.18K | -89.75%249.82K | 42.86%2.39M | -71.96%809.16K |
| Current changes in cash | -122.87%-18.67K | -1,335.35%-197.96K | 134.94%71.85K | 96.28%-79.62K | 111.31%58.18K | 114.15%81.63K | 98.46%-13.79K | -33.94%-205.63K | -398.48%-2.14M | -14.52%-514.5K |
| End cash Position | -77.32%25.41K | 45.05%44.08K | 447.85%242.04K | -31.87%170.2K | -31.87%170.2K | -86.16%112.02K | -97.81%30.39K | -98.06%44.18K | -89.55%249.82K | -89.55%249.82K |
| Free cash from | 46.33%-348.7K | -48.61%-706.1K | -95.40%-521.7K | -17.48%-2.29M | -102.06%-902.11K | -20.54%-649.73K | 44.18%-475.15K | -130.56%-266.99K | -65.99%-1.95M | -8.33%-446.47K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data